We have developed an ultra-thin device for conversion of light frequencies from infrared to visible wavelengths. This technology can be applied as a film to any glass surface and allows us to overcome many of the limitations of current night vision technologies.
[Detail]
Novel, highly potent peptide inhibitors of the Kv1.3 potassium channel, an emerging target for autoimmune diseases. The Monash peptides offer numerous advantages, including high Kv1.3 selectivity, minimising the potential for off-target side effects, efficacy across a range of experimental models an.....
[Detail]
 |
Use of single nucleotide polymorphisms (SNPs) in transient receptor potential (TRP) ion channel, acetylcholine receptor (AchR) and/or adrenergic receptor (ADR) genes as probes, tools or reagents for identifying, screening, diagnosing, monitoring or managing/treating subjects with, or predisposed to,.....
[Detail]
A series of novel and potent inhibitors of the histone acetyltransferase monocytic zinc finger leukaemia proteinMOZ (MYST3, KAT6A) with potential application in treating cancers
[Detail]
 |
Q-switched (pulsed) crystalline Raman laser. Also applicable to continuous wave (CW) operation
[Detail]
 |
| |< <- | [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] | -> >| |
